Predicted Trait | |
Reported Trait | Breast cancer |
Mapped Trait(s) | breast carcinoma (EFO_0000305) |
Score Construction | |
PGS Name | PRS15_BC |
Development Method | |
Name | Variants significantly associated with breast cancer |
Parameters | NR |
Variants | |
Original Genome Build | GRCh37 |
Number of Variants | 15 |
Effect Weight Type | log(OR) |
PGS Source | |
PGS Catalog Publication (PGP) ID | PGP000259 |
Citation (link to publication) | Yiangou K et al. Cancers (Basel) (2021) |
Ancestry Distribution | |
Source of Variant Associations (GWAS) | |
Score Development/Training | European: 100% 112,304 individuals (100%) |
PGS Evaluation | European: 100% 1 Sample Sets |
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
---|---|---|---|
GWAS Catalog: GCST004948 Europe PMC: 19330027 |
754 individuals | European | NR |
GWAS Catalog: GCST000035 Europe PMC: 17529967 |
754 individuals | European | EPIC-Norfolk |
Europe PMC: 22267197 |
[
|
European, Asian unspecified | 42 cohorts
|
GWAS Catalog: GCST000037 Europe PMC: 17529974 |
13,145 individuals | European | 7 cohorts
|
GWAS Catalog: GCST000365 Europe PMC: 19330030 |
2,287 individuals | European | NHS |
GWAS Catalog: GCST000343 Europe PMC: 19219042 |
3,027 individuals | East Asian | NBHS, SBCS, SECS |
GWAS Catalog: GCST000678 Europe PMC: 20453838 |
8,556 individuals | European | B58C, FBCS, POSH, UKBS |
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) | Phenotype Definitions & Methods | Age of Study Participants | Participant Follow-up Time | Additional Ancestry Description | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
GWAS Catalog: GCST007236 Europe PMC: 25751625 |
89,677 individuals | European | 42 cohorts
|
— | — | — | — | — |
GWAS Catalog: GCST001937 Europe PMC: 23535729 |
22,627 individuals | European | NR | — | — | — | — | — |
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|
PPM009262 | PSS007670| European Ancestry| 1,780 individuals |
PGP000259 | Yiangou K et al. Cancers (Basel) (2021) |
Reported Trait: Breast cancer | OR: 1.66 [1.25, 2.2] | AUROC: 0.548 | — | Age | — |
PPM009264 | PSS007670| European Ancestry| 1,780 individuals |
PGP000259 | Yiangou K et al. Cancers (Basel) (2021) |
Reported Trait: Breast cancer | OR: 1.57 [1.18, 2.08] | AUROC: 0.578 | — | Age, family history | — |
PPM009261 | PSS007670| European Ancestry| 1,780 individuals |
PGP000259 | Yiangou K et al. Cancers (Basel) (2021) |
Reported Trait: Breast cancer | OR: 1.66 [1.25, 2.19] | AUROC: 0.547 [0.52, 0.57] | — | — | — |
PPM009263 | PSS007670| European Ancestry| 1,780 individuals |
PGP000259 | Yiangou K et al. Cancers (Basel) (2021) |
Reported Trait: Breast cancer | OR: 1.56 [1.18, 2.08] | AUROC: 0.578 | — | Family history | — |
PPM009265 | PSS007670| European Ancestry| 1,780 individuals |
PGP000259 | Yiangou K et al. Cancers (Basel) (2021) |
Reported Trait: Breast cancer | — | AUROC: 0.6975 [0.673, 0.722] | Odds Ratio (OR, top 10% vs middle10%): 4.58 [2.88, 7.4] | Age at interview, menopausal status, age at menarche, age at first full-term pregnancy(1-4), parous, breast feeding, smoking status, body mass index, height, hormone-replacement therapy ever use, family history | — |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS007670 | Cases were individuals who had been diagnosed with breast cancer. | — | [ ,
0.0 % Male samples |
— | European (Greek-Cypriot) |
— | NR | Cases and controls were obtained from the MASTOS study. |